0001209191-21-047388.txt : 20210720 0001209191-21-047388.hdr.sgml : 20210720 20210720164505 ACCESSION NUMBER: 0001209191-21-047388 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210716 FILED AS OF DATE: 20210720 DATE AS OF CHANGE: 20210720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HALE DAVID F CENTRAL INDEX KEY: 0001024004 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36284 FILM NUMBER: 211101641 MAIL ADDRESS: STREET 1: 1042-B NORTH EL CAMINO REAL, SUITE 430 CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCEPT INC CENTRAL INDEX KEY: 0001044378 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 800943522 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9955 MESA RIM ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-320-8200 MAIL ADDRESS: STREET 1: 9955 MESA RIM ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-16 0 0001044378 BIOCEPT INC BIOC 0001024004 HALE DAVID F C/O BIOCEPT, INC. 9955 MESA RIM ROAD SAN DIEGO CA 92121 1 0 0 0 Employee Stock Option (right to buy) 3.77 2021-07-16 4 A 0 10000 0.00 A 2031-07-15 Common Stock 10000 10000 D The shares subject to the option shall be 100% vested and exercisable on July 16, 2022. /s/ Michael W. Nall, Attorney-in-fact 2021-07-20